Fundraising FoxEndotronix
Woodridge, US · Delaware corporation · 8 known investors
Find your way into Endotronix
Each arrow is one introduction. Sign up to fill in the first one.
Ask Paul LaViolette to introduce you to Harry Rowland
You →Paul · together at Endotronix →Harry
Sign up to find every way you can get introduced to Endotronix
- Your email: who you already know at Endotronix, and who your contacts know
- 2nd- and 3rd-degree connections: people you know who worked, studied or invested with the Endotronix team
- Your LinkedIn: the connections who can make the intro for you
We rank every route by how warm it is, so you raise on warm intros instead of cold emails.
Endotronix develops the Cordella PA Sensor and Heart Failure System, an FDA-approved implantable pulmonary artery pressure sensor and remote monitoring platform for managing patients with NYHA class III heart failure. The system enables clinicians to remotely optimize heart failure medication and supports patient self-monitoring.
Founders & leadership
Board
Investors · 8
How we know: APERTURE Venture Partners's portfolio page · press coverage · Not right? Tell us
How we know: press coverage · open dataset · 5k.vc investor directory · Not right? Tell us
How we know: Jumpstart Ventures's portfolio page · Not right? Tell us
How we know: Lumira Ventures's portfolio page · board seat on SEC Form D · funding news · press coverage · Not right? Tell us
How we know: press coverage · Not right? Tell us
How we know: press coverage · Not right? Tell us
How we know: SV Health Investors's portfolio page · a partner's Signal profile · board seat on SEC Form D · press coverage · open dataset · 5k.vc investor directory · Not right? Tell us
How we know: a partner's Signal profile · Not right? Tell us
Reported raises · per SEC filings
Form D private placements$113.1M disclosed across 5 rounds · 2014–2018
▶$69.3MraisedDec 2020 · 38 investors · Other Health CareRule 506(b)
- Fouad AzzamDirector
- John FlavinExecutive Officer
- Robert ZieserlDirector
- Paul LaVioletteDirector
- Marc GoldbergDirector
- Gerry BrunkDirector
- James HummerDirector
- Jennifer McMahonDirector
- Harry RowlandExecutive Officer, Director
- Offering amount
- $90.8M
- Amount sold
- $69.3M
- First sale
- Sep 2018
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$37.1MraisedFeb 2018 · 52 investors · Other Health CareRule 506(b)
- Paul LaVioletteDirector
- Gerry BrunkDirector
- Robert ZieserlDirector
- Harry RowlandExecutive Officer, Director
- Kent ElmerExecutive Officer
- Marc GoldbergDirector
- James HummerDirector
- Jennifer McMahonDirector
- Offering amount
- $37.1M
- Amount sold
- $37.1M
- First sale
- Jul 2016
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$3MraisedDec 2015 · 25 investors · Other Health CareRule 506(b)
- Jonathan JonasDirector
- Sam R. LenoDirector
- Harry RowlandExecutive Officer, Director
- Leslie SaxonDirector
- Anthony I NunezExecutive Officer, Director
- Raymond S. Barrett, Jr.Director
- James J. HummerDirector
- Offering amount
- $3.5M
- Amount sold
- $3M
- First sale
- Jun 2015
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$2.2MraisedFeb 2015 · 10 investors · Other Health CareRule 506(b)
- Jonathan JonasDirector
- Harry RowlandExecutive Officer, Director
- Raymond S. Barrett, Jr.Director
- Anthony I NunezExecutive Officer, Director
- Sam R. LenoDirector
- Leslie A. SaxonDirector
- James J. HummerDirector
- Offering amount
- $2.5M
- Amount sold
- $2.2M
- First sale
- Jul 2014
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$1.6MraisedApr 2014 · 4 investors · Other Health CareRule 506(b)
- Harry RowlandExecutive Officer, Director
- Sam R. LenoDirector
- James J. HummerDirector
- Leslie A. SaxonDirector
- Anthony A. NunezExecutive Officer, Director
- Raymond S. Barrett, Jr.Director
- Offering amount
- $3M
- Amount sold
- $1.6M
- First sale
- Mar 2014
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Founder mafia
2 people who came through Endotronix went on to found or lead other companies.
Related companies · 3
Companies working in the same space as Endotronix.
In the news
Frequently asked questions
- What does Endotronix do?
- Endotronix develops the Cordella PA Sensor and Heart Failure System, an FDA-approved implantable pulmonary artery pressure sensor and remote monitoring platform for managing patients with NYHA class III heart failure. The system enables clinicians to remotely optimize heart failure medication and supports patient self-monitoring.
- Who founded Endotronix?
- Endotronix was founded by Harry Rowland, Anthony Nunez.
- Who are Endotronix's investors?
- Endotronix's investors include APERTURE Venture Partners, Bioventures Investors, Jumpstart Ventures, Lumira Ventures, OSF Ventures, Seroba Life Sciences, SV Health Investors, LSP (Life Sciences Partners).
- How much funding has Endotronix raised?
- Endotronix has disclosed $113.1M raised across 5 rounds.
- Where is Endotronix headquartered?
- Endotronix is headquartered in Woodridge, US.